Crystallization and preliminary X-ray analysis of human uridine-cytidine kinase 2

被引:7
|
作者
Suzuki, NN
Koizumi, K
Fukushima, M
Matsuda, A
Inagaki, F
机构
[1] Hokkaido Univ, Grad Sch Pharmaceut Sci, Div Struct Biol, Kita Ku, Sapporo, Hokkaido 0600812, Japan
[2] Japan Sci & Technol Corp, CREST, Kawaguchi 3320012, Japan
[3] Taiho Pharmaceut Co, Canc Lab, Saitama 3578527, Japan
[4] Hokkaido Univ, Grad Sch Pharmaceut Sci, Div Med Chem, Kita Ku, Sapporo, Hokkaido 0600812, Japan
关键词
D O I
10.1107/S0907444903011533
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Uridine-cytidine kinase (UCK), which converts uridine and cytidine to their corresponding monophosphates, is a rate-limiting enzyme involved in the salvage pathway of pyrimidine- nucleotide biosynthesis. Two members of human UCK, named UCK1 and UCK2, were cloned recently and UCK2 was reported to play a crucial role in activating anti-tumour pro-drugs in human cancer cells. Human UCK2 was expressed, purified and crystallized alone or in complex with various ligands. Free UCK and UCK complexes were crystallized in six crystal forms. Form I (ligand-free) belongs to space group P2(1)2(1)2, with unit-cell parameters a = 83.1, b = 93.7, c = 157.1 Angstrom. Forms IIa ( with CTP), IIb ( with UTP) and IIc ( with cytidine) belong to space group F222, with unit-cell parameters a = 133.3, b = 247.3, c = 91.6 Angstrom ( IIa), a = 132.1, b = 247.0, c = 91.5 Angstrom ( IIb) and a = 136.7, b = 246.3, c = 90.4 Angstrom (IIc), respectively. Form III (with ATPgammaS) belongs to space group C222(1), with unit-cell parameters a = 70.3, b = 149.9, c = 117.2 Angstrom. Form IV ( with cytidine and ATP) belongs to space group C2, with unit-cell parameters a = 89.0, b = 109.7, c = 64.8 Angstrom, beta = 95.3degrees. Diffraction data were collected from these crystals; form IV diffracted to 1.8 Angstrom resolution.
引用
收藏
页码:1477 / 1478
页数:2
相关论文
共 50 条
  • [1] Phosphorylation of uridine and cytidine by uridine-cytidine kinase
    Qian, Yahui
    Ding, Qingbao
    Li, Yanyu
    Zou, Zhi
    Yan, Bingkun
    Ou, Ling
    [J]. JOURNAL OF BIOTECHNOLOGY, 2014, 188 : 81 - 87
  • [2] Structure of human uridine-cytidine kinase 2 determined by SIRAS using a rotating-anode X-ray generator and a single samarium derivative
    Appleby, TC
    Larson, G
    Cheney, IW
    Walker, H
    Wu, JZ
    Zhong, WD
    Hong, Z
    Yao, NH
    [J]. ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY, 2005, 61 : 278 - 284
  • [3] SUBSTRATE COMPETITION PATTERNS FOR URIDINE-CYTIDINE KINASE
    LIACOURAS, AS
    ANDERSON, EP
    [J]. PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1976, 17 (MAR): : 78 - 78
  • [4] REGULATION OF MAMMALIAN URIDINE-CYTIDINE KINASE ACTIVITY
    ORENGO, A
    [J]. FEDERATION PROCEEDINGS, 1969, 28 (02) : 885 - &
  • [5] URIDINE-CYTIDINE KINASE .3. COMPETITION BETWEEN URIDINE AND CYTIDINE FOR A SINGLE ENZYME
    LIACOURAS, AS
    ANDERSON, EP
    [J]. MOLECULAR AND CELLULAR BIOCHEMISTRY, 1977, 17 (03) : 141 - 146
  • [6] Crystallization and preliminary x-ray analysis of human muscle creatine kinase
    Tang, L
    Zhou, HM
    Lin, ZJ
    [J]. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 1999, 55 : 669 - 670
  • [7] The Cytidine Analog Fluorocyclopentenylcytosine (RX-3117) Is Activated by Uridine-Cytidine Kinase 2
    Sarkisjan, Dzjemma
    Julsing, Joris R.
    Smid, Kees
    de Klerk, Daniel
    van Kuilenburg, Andre B. P.
    Meinsma, Rutger
    Lee, Young B.
    Kim, Deog J.
    Peters, Godefridus J.
    [J]. PLOS ONE, 2016, 11 (09):
  • [8] Structural basis for the specificity, catalysis, and regulation of human uridine-cytidine kinase
    Suzuki, NN
    Koizumi, K
    Fukushima, M
    Matsuda, A
    Inagaki, F
    [J]. STRUCTURE, 2004, 12 (05) : 751 - 764
  • [9] SOME PROPERTIES OF URIDINE-CYTIDINE KINASE FROM A HUMAN-MALIGNANT LYMPHOMA
    AHMED, NK
    WELCH, AD
    [J]. CANCER RESEARCH, 1979, 39 (08) : 3102 - 3106
  • [10] Phosphorylation of uridine and cytidine nucleoside analogs by two human uridine-cytidine kinases
    Van Rompay, AR
    Norda, A
    Lindén, K
    Johansson, M
    Karlsson, A
    [J]. MOLECULAR PHARMACOLOGY, 2001, 59 (05) : 1181 - 1186